Skip to content
10-K

Annual Report

ANIXA BIOSCIENCES, INC. ANIX

0001493152-24-002453

← back to feed
Filed
Jan 16, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jan 16, 2024 31.7M sh
Shares Diluted restated FY 2023 · Oct 31, 2022 30.37K sh
Operating Cash Flow FY 2023 · Oct 31, 2022 −$6.49M
Short Term Investments FY 2023 · Oct 31, 2022 $17.33M
Cash And Equivalents FY 2023 · Oct 31, 2022 $12.36M
Stockholders Equity FY 2023 · Oct 31, 2022 $29.05M
Current Liabilities FY 2023 · Oct 31, 2022 $2.04M
Total Liabilities FY 2023 · Oct 31, 2022 $2.21M
Current Assets FY 2023 · Oct 31, 2022 $30.2M
Total Assets FY 2023 · Oct 31, 2022 $30.41M
Eps Diluted FY 2023 · Oct 31, 2022 $0.45
Eps Basic restated FY 2023 · Oct 31, 2022 $0.45
Rd Expense FY 2023 · Oct 31, 2022 $6.7M
Net Income FY 2023 · Oct 31, 2022 −$13.6M
Operating Income FY 2023 · Oct 31, 2022 −$13.88M